AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Centessa Pharmaceuticals plc Director's Dealing 2022

Nov 23, 2022

31309_dirs_2022-11-23_18587bed-8ce0-4db2-b7a2-e8a21c3e61b1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Centessa Pharmaceuticals plc (CNTA)
CIK: 0001847903
Period of Report: 2022-09-30

Reporting Person: HUSSAIN IQBAL J (General Counsel)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	163000	Direct

Footnotes

F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2: The transactions previously reported on the Form 4 filed on October 4, 2022 were canceled in their entirety before settlement by the broker without instruction from the Issuer or Reporting Person.